USE OF PROTEINASE INHIBITORS IN THE TREATMENT OF AUTOIMMUNE DISEASES

Details for Australian Patent Application No. 2003206945 (hide)

Owner MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.

Inventors SONDERMANN, Peter; HUBER, Robert; JACOB, Uwe

Pub. Number AU-A-2003206945

PCT Number PCT/EP03/01807

PCT Pub. Number WO2003/070229

Priority 102 07 744.4 22.02.02 DE; 102 41 411.4 06.09.02 DE

Filing date 21 February 2003

Wipo publication date 9 September 2003

International Classifications

A61K 031/00

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 102 07 744.4 22.02.02 DE; 102 41 411.4 06.09.02 DE

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003206945

11 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003206946-AGENT FOR INHIBITING DEVELOPMENT OR PROGRESS OF PROLIFERATIVE DISEASES AND ESPECIALLY CANCER DISEASES AND PHARMACEUTICAL COMPOSITION CONTAINING SAID AGENT

2003206944-NUCLEIC ACID ENCODING AN HERV-H POLYPEPTIDE FOR DIAGNOSING COLORECTAL CANCER